Guzzardi, David G.
White, James A.
Labib, Dina
Dykstra, Steven
Flewitt, Jacqueline
Feuchter, Patricia
Sandonato, Rosa
Howarth, Andrew G.
Lydell, Carmen P.
Fine, Nowell M.
Greiner, Russel
Satriano, Alessandro
Funding for this research was provided by:
Canadian Institutes of Health Research (10020327, 10020327)
Article History
Received: 14 March 2022
Accepted: 3 July 2022
First Online: 23 July 2022
Declarations
:
: JAW receives research support from Siemens Healthineers, Circle Cardiovascular Inc, and Pfizer Inc. and is chief medical officer and a shareholder of Cohesic Inc. AGH is a shareholder of Cohesic Inc. AS is a shareholder in and receives consulting fees from Vitaa Medical Solutions Inc.
: Not applicable.
: The study design was approved by the Conjoint Health Research Ethics Board at the University of Calgary and all subjects provided written informed consent. All research activities were performed in accordance with the Declaration of Helsinki.